Evidence map›Paper›PMID 33089120›Full record

ArticleEClinicalMedicine2020

Changes in mental health and drug use among men who have sex with men using daily and event-driven pre-exposure prophylaxis: Results from a prospective demonstration project in Amsterdam, the Netherlands.

R C A Achterbergh, E Hoornenborg, A Boyd, L Coyer, S J A Meuzelaar, A A Hogewoning, U Davidovich, M S van Rooijen, M F Schim van der Loeff, M Prins and 1 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

R C A AchterberghSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
E HoornenborgSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
A BoydResearch and Prevention, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
L CoyerResearch and Prevention, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
S J A MeuzelaarSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
A A HogewoningSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
U DavidovichResearch and Prevention, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
M S van RooijenSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
M F Schim van der LoeffResearch and Prevention, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
M PrinsResearch and Prevention, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
H J C de VriesSTI outpatient clinic, Department of infectious diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
GGD Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGay, bisexual and other men who have sex with men (GBMSM) are at increased risk of mental health disorders and drug use. In GBMSM taking pre-exposure prophylaxis (PrEP) for HIV, the proportion engaging in risk behaviors could increase due to decreased perception in HIV risk. In turn, this could leave them further susceptible to mental health disorders.

methodsThe AMsterdam PrEP study (AMPrEP) is a demonstration project offering a choice of daily PrEP or event-driven PrEP regimen at the STI clinic of the Public Health Service of Amsterdam. Eligible participants were HIV-negative GBMSM and transgender people at risk of HIV, aged ≥18 years. We assessed anxiety and depressive mood disorders (Mental Health Inventory 5), sexual compulsivity (Sexual Compulsivity Scale), alcohol use disorder (Alcohol Use Disorder Identification Test), and drug use disorder (Drug Use Disorder Identification Test) using yearly self-administered assessments (August 2015-September 2018). The proportion of mental health problems were analyzed and changes over time and between regimen were assessed using a logistic regression model. Variables associated with the development or recovery of disorders were assessed using a multistate Markov model. OUTCOMES: Of 376 enrolled, we analyzed 341 participants with data at baseline and at least one follow-up visit. During a median follow-up of 2.5 years (IQR=2.3-2.7), the proportion assessed with sexual compulsivity decreased from 23% at baseline to 10% at the last visit (

interpretationMental health disorders are prevalent among those initiating PrEP. We did not find increases in mental health disorders during PrEP use, but rather a decrease in sexual compulsivity and drug use disorders. The initial prevalence of mental health disorders in our study point at the continuous need to address mental health disorders within PrEP programs.

fundingZonMw, H-TEAM, Internal GGD research funds, Aidsfonds, Stichting AmsterdamDiner Foundation, Gilead Sciences, Janssen Pharmaceutica, M A C AIDS Fund, and ViiV Healthcare.

Indexed as

HIVHomosexuality maleMental healthPre-exposure prophylaxisRisk behaviorSubstance useSyndemicsTransgender persons

Identifiers

PMID33089120
PMCPMC7564518
OpenAlexW3073035879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.